The purpose of compliance readiness
Compliance readiness is the process of validating that the systems, roles, and documentation needed to manage pharmacovigilance are in place before a product is marketed or a new country launch begins. It is purpose-built to help organizations avoid regulatory gaps, unnecessary work, and last-minute responses to audit requests.
For life sciences organizations operating in Nigeria and other African markets, readiness means more than having a policy. It means verifying that safety reporting pathways, case management capacity, and local representation are aligned with both global standards and local expectations.
Why pharmaceutical companies need it
Pharmaceutical companies need compliance readiness because regulatory authorities are increasingly focused on how well systems work in practice, not simply whether paperwork has been filed. A readiness review helps companies identify weaknesses in their process before they become a compliance risk.
When a company can demonstrate operational consistency around safety reporting, quality oversight, and escalation, it is better positioned for faster market access and smoother regulatory interactions. That is especially important when working with NAFDAC, where expectations for local oversight and safety governance remain high.
Benefits of a structured checklist
- Creates a clear view of responsibilities for QPPV, local safety staff, and the business team.
- Identifies gaps in case intake, triage, documentation, and reporting before inspection.
- Supports better coordination between pharmacovigilance, regulatory affairs, and commercial functions.
- Improves the likelihood that submissions and incident reports are ready on schedule.
How to use this checklist
Use the checklist as a structured framework for review meetings, handover sessions, and operational readiness assessments. It should be applied early in the lifecycle so the organization has time to strengthen governance, define roles, and document critical processes.
For each checklist item, confirm that a responsible owner is assigned, evidence is available, and the team can describe how the process will function during routine operations and in a compliance review.
Checklist explanation
The checklist is designed to help you assess four fundamental areas: governance, safety reporting, documentation, and inspection readiness. Governance covers both the QPPV role and the local escalation path. Safety reporting covers case processing, signal review, and communication pathways. Documentation covers procedures, logbooks, and training records. Inspection readiness covers how the organization prepares for regulatory review.
When this matters most
Compliance readiness is especially valuable in the months before a new registration, a major submission, or a planned product launch. It is also useful when a company is onboarding a new pharmacovigilance partner, changing a contract research organization, or expanding into a new market.
When readiness is reviewed early, it becomes a competitive advantage rather than a reactive burden.
Common audit findings
- Unclear or incomplete QPPV governance and local representation.
- Insufficient documentation of safety reporting workflows and case processing responsibilities.
- Missing or outdated training records for staff responsible for adverse event intake.
- Weak escalation pathways between pharmacovigilance, medical writing, and regulatory teams.
- Inspection evidence that is separated from the operational process rather than linked to live case management.
Best practices
- Keep a current pharmacovigilance governance chart that identifies the QPPV and local safety contacts.
- Document case intake, triage, and reporting procedures in a way that can be followed by new staff and inspectors alike.
- Align your SOPs with NAFDAC expectations and global guidance such as Good Pharmacovigilance Practice.
- Run sample case reviews to test the end-to-end safety reporting process and correct gaps before they become a compliance issue.
- Maintain an inspection-ready evidence package that includes training records, safety reports, and a clear escalation path.
The checklist helps teams move from abstract compliance goals to practical, auditable preparation. If you want to validate your readiness with experienced local support, contact MedNova Lifesciences and we will help you translate the checklist into a focused action plan.